Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 4, 2026, 12:00 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 697–720 of 10,295 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: PAIN Clear all

Conditions: Pain, Postoperative
Interventions: Naproxen sodium 440 mg / DPH 50 mg (BAY98-7111), Naproxen sodium 220 mg / DPH 50 mg (BAY98-7111), Naproxen sodium 440 mg (BAYH6689), DPH 50 mg; Drug
Lead sponsor: Bayer; Industry
Eligibility: 12 Years to 45 Years
Enrollment: 712 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2011
U.S. locations: 2
States / cities: Austin, Texas • Salt Lake City, Utah

Conditions: Painful Diabetic Neuropathy, Diabetic Neuropathy, Painful
Interventions: Long-Term Follow-Up of Patients who Received Engensis (VM202), Long-Term Follow-Up of Patients who Received Placebo; Genetic · Drug
Lead sponsor: Helixmith Co., Ltd.; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 101 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019
U.S. locations: 14
States / cities: Phoenix, Arizona • Little Rock, Arkansas • Sacramento, California + 11 more

Conditions: Migraine
Interventions: Rimegepant, Placebo; Drug
Lead sponsor: Pfizer; Industry
Eligibility: 18 Years and older
Enrollment: 962 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2025
U.S. locations: 23
States / cities: Los Angeles, California • Sherman Oaks, California • Stamford, Connecticut + 20 more

Conditions: Neonatal Procedural Pain
Interventions: 24% oral sucrose, 30% oral glucose; Other
Lead sponsor: Loma Linda University; Other
Eligibility: Up to 7 Days
Enrollment: 51 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2020
U.S. locations: 1
States / cities: Loma Linda, California

Conditions: Chronic Low Back Pain
Interventions: Pregnenolone, DHEA, Placebo; Drug
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 18 Years to 65 Years
Enrollment: 108 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2029
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Pain
Interventions: LMX4, BLT; Drug
Lead sponsor: Milton S. Hershey Medical Center; Other
Eligibility: 18 Years to 75 Years
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013
U.S. locations: 1
States / cities: Hershey, Pennsylvania

Conditions: TMD
Interventions: Injection of Nerve Growth Factor; Other
Lead sponsor: University of Maryland, Baltimore; Other
Eligibility: 18 Years to 44 Years
Enrollment: 159 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2022
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Low Back Pain, Obesity
Interventions: normal medical care and follow up, Isolated Lumbar Resistance Exercise Program, Total Body Resistance Exercise Program; Other
Lead sponsor: University of Florida; Other
Eligibility: 60 Years to 85 Years
Enrollment: 72 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2014
U.S. locations: 1
States / cities: Gainesville, Florida

Conditions: Opioid Use, Pain, Hypogonadism, Male
Interventions: Testosterone Undecanoate 250 MG/ML, Placebo; Drug
Lead sponsor: Brigham and Women's Hospital; Other
Eligibility: 18 Years and older · Male only
Enrollment: 150 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2027
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Chronic Pain
Interventions: Recorded Hypnosis Intervention, Recorded Relaxation Intervention; Behavioral
Lead sponsor: University of Washington; Other
Eligibility: 18 Years to 90 Years
Enrollment: 109 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2021
U.S. locations: 2
States / cities: Chicago, Illinois • Seattle, Washington

Conditions: Sciatica, Radiculopathy
Interventions: epidural steroid injection, Sham epidural steroid injection, Gabapentin, Placebo gabapentin; Procedure · Drug
Lead sponsor: Johns Hopkins University; Other
Eligibility: 17 Years to 100 Years
Enrollment: 145 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2014
U.S. locations: 3
States / cities: San Diego, California • Baltimore, Maryland • Bethesda, Maryland

Conditions: Fibromyalgia, Complex Regional Pain Syndromes, Chronic Pain
Interventions: Low-intensity Focused Ultrasound (LIFU), Sham Low-intensity focused ultrasound (LIFU); Device
Lead sponsor: Carilion Clinic; Other
Eligibility: 18 Years to 65 Years
Enrollment: 27 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2025
U.S. locations: 1
States / cities: Roanoke, Virginia

Conditions: Rotator Cuff Tears
Interventions: suture anchor socket creation with punch, suture anchor socket creation with drill; Procedure
Lead sponsor: Matt Smith; Other
Eligibility: 18 Years to 80 Years
Enrollment: 43 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2023
U.S. locations: 1
States / cities: Columbia, Missouri

Conditions: Postoperative Pain, Shoulder Arthritis
Interventions: Liposomal Bupivacaine Infiltration, Continuous Perineural Ropivicaine Infusion; Drug
Lead sponsor: Eric Shepard; Other
Eligibility: 18 Years and older
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2017
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Chronic Pain, Abdominal Pain, Headache
Interventions: Problem-Solving Skills Training; Behavioral
Lead sponsor: Seattle Children's Hospital; Other
Eligibility: 10 Years to 17 Years
Enrollment: 122 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2015
U.S. locations: 2
States / cities: Portland, Oregon • Seattle, Washington

Conditions: Non-Specific Chronic Lower Back Pain
Interventions: NexWave, Sham; Device
Lead sponsor: Zynex Medical, Inc.; Industry
Eligibility: 18 Years to 70 Years
Enrollment: 334 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2025
U.S. locations: 8
States / cities: Greenwood Village, Colorado • Saint Augustine, Florida • Atlanta, Georgia + 5 more

Conditions: Pain, Postoperative
Interventions: Twin block, iPill dispenser; Drug · Device
Lead sponsor: Rutgers, The State University of New Jersey; Other
Eligibility: 18 Years and older
Enrollment: 133 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2030
U.S. locations: 1
States / cities: New Brunswick, New Jersey

Conditions: Cataract
Interventions: MELT-300, Midazolam alone, Ketamine alone, Placebo; Drug
Lead sponsor: Melt Pharmaceuticals; Industry
Eligibility: 55 Years and older
Enrollment: 338 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2022
U.S. locations: 3
States / cities: Rancho Cordova, California • Jacksonville, Florida • West Fargo, North Dakota

Conditions: Pain
Interventions: Oxycodone hydrochloride controlled-release tablets; Drug
Lead sponsor: Purdue Pharma LP; Industry
Eligibility: 6 Years to 17 Years
Enrollment: 23 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2014
U.S. locations: 13
States / cities: Birmingham, Alabama • Paramount, California • Aurora, Colorado + 10 more

Conditions: Shoulder Impingement Syndrome
Interventions: Manual Physical Therapy, Corticosteroid Injection; Procedure
Lead sponsor: Madigan Army Medical Center; Federal
Eligibility: 18 Years and older
Enrollment: 104 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2013
U.S. locations: 1
States / cities: Tacoma, Washington

Conditions: Achilles Tendon Pain
Interventions: Ropivacaine injection; Drug
Lead sponsor: Ruth Chimenti; Other
Eligibility: 18 Years to 70 Years
Enrollment: 46 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2018
U.S. locations: 1
States / cities: Iowa City, Iowa

Conditions: Malignant Neoplasms of Independent (Primary) Multiple Sites
Interventions: Questionnaires; Behavioral
Lead sponsor: M.D. Anderson Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 201 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2023
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Chronic Low-back Pain
Interventions: Mindfulness-based dance/movement therapy (M-DMT), Chronic pain social support group; Behavioral
Lead sponsor: Drexel University; Other
Eligibility: 18 Years and older
Enrollment: 66 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2022
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Intestinal Stricture, Crohn Disease, NSAID (Non-Steroidal Anti-Inflammatory Drug) Induced Enteropathy, Abdominal Pain
Interventions: NaviCam Patency Capsule; Device
Lead sponsor: AnX Robotica Corp.; Industry
Eligibility: 22 Years and older
Enrollment: 25 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Downers Grove, Illinois

Search by objective public record fields.

Evaluate Analgesic/Sedative Efficacy of Naproxen Sodium and Diphenhydramine in Patients With Postsurgical Dental Pain

Extension of Phase 3 Gene Therapy for Painful Diabetic Neuropathy

Efficacy and Tolerability of Rimegepant for the Prevention of Migraine in Adults With History of Inadequate Response to Oral Preventive Medications

Oral Sucrose Versus Glucose for Procedural Pain in Premature Neonates

Investigating Novel Interventions for Low Back Pain in US Military Veterans: A Randomized Controlled Adaptive Phase II Trial

Comparison Study on Topical Anesthetic Agents (LMX4 and BLT) Prior to Fractional Skin Resurfacing

Validation of a Novel Cortical Biomarker Signature for Pain

Resistance Exercise Effects on Fear Avoidance and Physical Function in Obese Older Adults With Low Back Pain

Pain Alleviation With Testosterone in Opioid-Induced Hypogonadism

Self-Management Interventions for Chronic Pain Relief With Cancer Survivors

Steroids Versus Gabapentin

Low-Intensity Focused Ultrasound For Insular Neuromodulation in Chronic Pain

Punch vs. Drill Tunnel Use for Anchor Tunnel Creation and Correlation With Post-operative Pain

Liposomal Bupivacaine Infiltration vs Continuous Perineural Ropivacaine Infusion for Post-operative Pain After Total Shoulder Arthroplasty

Problem Solving Skills Training For Parent Caregivers of Youth With Chronic Pain

Randomized Blinded Evaluation of the Effects of TENS and IFC Compared to a Sham Device and SOC in Patients With Non-Specific CLBP

Reducing Opioid Use and Misuse After Wisdom Molar Extractions

A Study of MELT-300 (Midazolam and Ketamine Sublingual Tablets) for Sedation and Intraoperative Ocular Analgesia in Participants Undergoing Cataract Extraction With Lens Replacement (CELR)

Long-Term Safety of Twice Daily Oxycodone Hydrochloride Controlled-release Tablets in Children Who Completed OTR3001

Physical Therapy Versus Steroid Injection for Shoulder Impingement Syndrome

Achilles Pain Block

Chronic Non-Malignant Pain in Cancer Patients at a Supportive Care Clinic

Mindfulness-based Dance/Movement Therapy for Chronic Low Back Pain

NaviCam Patency Capsule to Verify Gastrointestinal Patency